StellarOne Corp’s AstraZeneca AZN Stock Holding History

StellarOne Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$9K	Hold	167	–	–	0.01%	178
2013 Q2	$8K	Buy	+167	New	+$8.5K	0.01%	186

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

StellarOne Corp's AZN Position: Q3 2013 in Review

StellarOne Corp held its AstraZeneca (AZN) position steady in Q3 2013 at 167 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #178.

StellarOne Corp first reported a position in AZN in Q2 2013 and has held it in 2 quarters since. 343 funds tracked by Wall St. Rank hold AZN as of Q3 2013.

StellarOne Corp held 167 shares of AstraZeneca worth $9K as of Q3 2013.
StellarOne Corp left its AstraZeneca share count unchanged in Q3 2013.
AstraZeneca made up 0.01% of StellarOne Corp's portfolio in Q3 2013, its #178 holding.
StellarOne Corp first reported a position in AstraZeneca in Q2 2013 and has held it in 2 quarters since.
343 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.